Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer
- 893 Downloads
The challenge of performing a good total mesorectal excision (TME) dissection, particularly in the distal 1/3 of the rectum, has spurred interest in new techniques. Robotic surgery is advocated by some, and more recently, a “new” approach, the transanal total mesorectal excision, has been popularized to address this problem. While great interest in this technique exists, little long-term outcome data are available. We have been utilizing a transanal abdominal transanal approach to TME in order to facilitate the distal dissection, and here, we provide our long-term outcomes using this approach in the management of rectal cancer.
From a prospectively maintained rectal cancer database, we identified 373 consecutive rectal cancers treated with sphincter preservation surgery through a combined transanal and abdominal approach to TME. Perioperative, pathological, and oncologic outcomes were analyzed.
Three hundred and seventy-three patients with rectal cancer underwent a transanally initiated TME with mean follow-up of 5.5 years. 91% of cancers were in the distal rectum. 68.9% were men and 53.2% of cancers were tethered or fixed on presentation. 97.7% received neoadjuvant radiotherapy (mean 5405 cGy, 5-fluorouracil based); average time from completion of neoadjuvant therapy to surgery was 11 weeks. 180 and 193 patients underwent completion of their operation through open and laparoscopic abdominal approaches. 96% of TME specimens were complete/near complete, 94% had a negative circumferential resection margin, and 98.6% had a negative distal margin. Perioperative morbidity and mortality rates were 13.4 and 0.3%. Overall local recurrence (LR), DM, and Kaplan–Meier 5-year actuarial survival were 7.4, 19.5, and 90%, respectively.
This is the first report of long-term data using a transanal approach to TME supporting this approach for rectal cancer. Our data with 5-year follow-up show that adequate distal and circumferential margins with very good-quality TME specimens, and a low risk for LR with excellent overall survival can be achieved using this technique. Our long-term results support the promising reports of early experiences in the literature.
KeywordsRectal cancer Transanal TME (taTME) TATA APR Sphincter preservation Laparoscopic rectal cancer TME NOTES
Supported by Harry Mirabile Colorectal Cancer Fund of the Marks Colorectal Surgical Foundation.
Compliance with ethical standards
John H. Marks, Elizabeth A. Myers, Erik L. Zeger, Albert S. Denittis, Mounica Gummadi and Gerald J. Marks have no conflicts of interest of financial ties to disclose
- 6.Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M et al (2015) Effect of laparoscopic-assisted resection vs. open resection of stage II or III rectal cancer on pathologic outcomes. The ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Marks JH, Valsdottir EB (2015) Total mesorectal excision with coloanal anastomosis: laparoscopic technique. In: Mulholland M (ed) Operative techniques in surgery, vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1177–1189Google Scholar
- 19.Buess G, Theiss R, Gunther M, Hutterer F, Hepp M, Pichlmaier H (1984) Endoscopic operative procedure for the removal of rectal polyps. Coloproctology 84:254–261Google Scholar
- 21.Atallah S, Martin-Perez B, Albert M, deBeche-Adams T, Nassif G, Hunter L, Larach S (2014) Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol 18(5):473–480CrossRefPubMedGoogle Scholar
- 22.Marks JH, Nassif G, Schoonyoung H, DeNittis A, Zeger E, Mohiuddin M, Marks GJ (2013) Sphincter-sparing surgery for adenocarcinoma of the distal 3 cm of the true rectum: results after neoadjuvant therapy and minimally invasive radical surgery or local excision. Surg Endosc 27:4469–4477CrossRefPubMedGoogle Scholar
- 23.Quirke P, Steele R, Monson J, MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821–828CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. J Clin Oncol 20(7):1729–1734CrossRefPubMedGoogle Scholar
- 32.Stevenson ARL, Solomon M, Lumley J, Hewett P, Clouston A, Gebski V, Davies L, Wilson K, Hague W, Simes J (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363CrossRefPubMedGoogle Scholar
- 33.Marks G, Mohiuddin M, Masoni L, Montori A (1992) High-dose preoperative radiation therapy as the key to extending sphincter preservation surgery for cancer of the distal rectum. Surg Oncol Clin N Am 1:71–85Google Scholar